Plague

Tropical Infectious Diseases

Volumn 1, Issue , 2006, Pages 471-481

  Dennis, David T ^a,b   Mead, Paul S ^b  

^a Veterinary Dentistry and Oral Surgery   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882479070     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-06668-9.50047-8     Document Type: Chapter

References (65)

1. Biological and chemical terrorism: Strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup. MMWR 2000, 49:1. Centers for Disease Control and Prevention.
2. Inglesby TV, Dennis DT, Henderson DA, et al. Plague as a biological weapon: Medical and public health management. JAMA 2000, 283:2281.
3. Pollitzer R Plague. WHO Monograph Series 22 1954, 1. World Health Organization, Geneva.
4. Perry RD, Fetherston JD Yersinia pestis-Etiologic agent of plague. Clin Microbiol Rev 1997, 10:35.
5. Link VB A History of Plague in the United States of America. Public Health Monograph No. 26 1955, Government Printing Office, Washington, DC.
6. Butler T Plague and Other Yersinia Infections 1983, Plenum Press, New York.
7. Gage KL Plague. Topley and Wilson's Microbiology and Microbial Infections 1998, 3:885. Arnold Publications, London. 9th ed. L. Collier, A. Balows, M. Sussman (Eds.).
8. Poland JD, Barnes AM Plague. CRC Handbook Series in Zoonoses, Section A: Bacterial, Rickettsial, and Mycotic Diseases 1979, 2:515. CRC Press, Boca Raton, FL. J.H. Steele (Ed.).
9. Gratz NG Control of plague transmission. Plague Manual: Epidemiology, Distribution, Surveillance and Control 1999, 97. World Health Organization, Geneva.
10. Boisier P, Rahalison L, Rasolomaharo M, et al. Epidemiological features of four successive annual outbreaks of bubonic plague in Mahajanga, Madagascar. Emerg Infect Dis 2002, 8:311.
11. International Health Regulations (1969) 1983, World Health Organization, Geneva.
12. Dennis DT Plague in India. BMJ 1994, 309:893.
13. Campbell GL, Hughes JM Plague in India: A new warning from an old nemesis. Ann Intern Med 1995, 122:151.
14. Chu MC: Laboratory Manual of Plague Diagnostic Tests. Atlanta, GA, USPHS Centers for Disease Control and Prevention, 2000. Centers for Disease Control and Prevention: Bioweapons Laboratory Issues. 2001. Full text available on the Internet:. http://www.bt.cdc.gov/Agent/Plague/ype_1a_cp/123010.pdf.
15. Achtman M, Zurth K, Morelli G, et al. Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis. Proc Natl Acad Sci USA 1999, 24:14043.
16. Parkhill J, Wren BW, Thompson NR, et al. Genome sequence of Yersinia pestis, the causative agent of plague. Nature 2001, 413:523.
17. Brubaker RR Factors promoting acute and chronic diseases caused by yersiniae. Clin Microbiol Rev 1991, 4:309.
18. Carniel E Evolution of pathogenic Yersinia, some lights in the dark. Adv Exp Med Biol 2003, 529:3.
19. Hinnebusch BJ Bubonic plague: A molecular genetic case history of the emergence of an infectious disease. J Mol Med 1997, 75:645.
20. Hinnebusch BJ, Rudolph AE, Cherepenov P, et al. Role of murine toxin in survival of Yersinia pestis in the midgut of the vector flea. Science 2002, 296:733.
21. Guiyoule A, Grimont F, Iteman I, et al. Plague pandemics investigated by ribotyping of Yersinia pestis strains. J Clin Microbiol 1994, 32:634.
22. Guiyoule A, Rasoamanana B, Buchrieser C, et al. Recent emergence of new variants of Yersinia pestis is Madagascar. J Clin Microbiol 1997, 35:2826.
23. Radnedge L, Agron PG, Worsham PL, et al. Genome plasticity in Yersinia pestis. Microbiology 2002, 148:1687.
24. Pollitzer R, Meyer KF The ecology of plague. Studies in Disease Ecology 1961, 433. Hefner, New York. J.H. May (Ed.).
25. Barnes AM Surveillance and control of bubonic plague in the United States. Symp Zool Soc London 1982, 50:237-270.
26. Gratz NG Rodent reservoirs and flea vectors of natural foci of plague. Plague Manual: Epidemiology, Distribution, Surveillance and Control 1999, 63. World Health Organization, Geneva.
27. Dennis DT, Orloski K Plague. 1996 Medical and Health Annual 1996, 160. Encyclopaedia Brittanica, Chicago. E. Bernstein, L. Tomchuck, J. Brant (Eds.).
28. Saxena VK, Vergese T Ecology of flea-transmitted zoonotic infection in village Mamla, District Beed. Curr Sci 1996, 71:800.
29. Craven RB, Maupin GO, Beard ML, et al. Reported cases of human plague infections in the United States, 1970-1991. J Med Entomol 1993, 30:758.
30. Gage KL, Dennis DT, Orloski KA, et al. Cases of cat-associated plague in the western U.S., 1977-1998. Clin Infect Dis 2000, 30:893.
31. Mann JM, Martone WJ, Boyce JM, et al. Endemic human plague in New Mexico: Risk factors associated with infection. J Infect Dis 1979, 140:397.
32. Christie AB, Chen TH, Elberg SS Plague in camels and goats: Their role in human epidemics. J Infect Dis 1980, 141:724.
33. Human plague in 2000 and 2001. Wkly Epidemiol Rec 2003, 78:130. World Health Organization.
34. Chanteau S, Ratsifasoamanana L, Rasoamanana B, et al. Plague, a reemerging disease in Madagascar. Emerg Infect Dis 1998, 4:101.
35. Dennis DT Plague as an emerging disease. Emerging Infections 2 1998, 169. ASM Press, Washington, DC. W.M. Scheld, W.A. Craig, J.M. Hughes (Eds.).
36. Butler T, Bell WR, Nguyen NL, et al. Yersinia pestis infection in Vietnam. I. Clinical and hematological aspects. J Infect Dis 1974, 129(Suppl):S78.
37. Butler T A clinical study of bubonic plague: Observations on the 1970 Vietnam epidemic with emphasis on coagulation studies, skin histology and electrocardiograms. Am J Med 1972, 53:268.
38. Hull HF, Montes JM, Mann JM Septicemic plague in New Mexico. J Infect Dis 1987, 155:113.
39. Butler T, Levin J, Nguyen NL, et al. Yersinia pestis infection in Vietnam. II. Quantitative blood cultures and detection of endotoxin in the cerebrospinal fluid of patients with meningitis. J Infect Dis 1976, 133:493.
40. Crook LD, Tempest B Plague-A clinical review of 27 cases. Arch Intern Med 1992, 152:1253.
41. Hull HF, Montes JM, Mann JM Plague masquerading as gastrointestinal illness. West J Med 1986, 145:485.
42. Wu Lien-Teh: A Treatise on Pneumonic Plague. Geneva, League of Nations Health Organization, 1926.
43. Becker TM, Poland JD, Quan TJ, et al. Plague meningitis-A retrospective analysis of reported cases in the United States, 1970-1979. West Med J 1987, 147:554.
44. Dennis D, Meier F Plague. Pathology of Emerging Infections 1997, 21. ASM Press, Washington, DC. C.R. Horsburgh, A.M. Nelson (Eds.).
45. Finegold MJ Pathogenesis of plague: A review of plague deaths in the United States during the last decade. Am J Med 1968, 45:549.
46. Burmeister RW, Tigertt WD, Overholt EL Laboratory-acquired pneumonic plague: Report of a case and review of previous cases. Ann Intern Med 1962, 56:789.
47. Cornelis GR Yersinia type III secretion: Send in the effectors. J Cell Biol 2002, 158:401.
48. Sing A, Rost D, Tvardovskaia N, et al. Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J Exp Med 2002, 196:1017.
49. Kopp E, Medzhitov R A plague on host defense. J Exp Med 2002, 196:1009.
50. Sodhi A, Sharma RK, Batra HV, et al. Mechanism of rLcrV and rYopB mediated immunosuppression in murine peritoneal macrophages. Mol Immunol 2004, 41:767.
51. Kerschen EJ, Cohen DA, Kaplan AM, et al. The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells. Infect Immun 2004, 72:4589.
52. Mann JM, Schmid GP, Stoetz PA, et al. Peripatetic plague. JAMA 1982, 247:46.
53. Imported plague- New York City, 2002. MMWR 2003, 52:725. Centers for Disease Control and Prevention.
54. Morse SA, Kellogg RB, Perry S Detecting biothreat agents: The laboratory response network. ASM News 2003, 69:433.
55. Butler T, Hudson BW The serological response to Yersinia pestis infection. Bull WHO 1977, 55:39.
56. Chanteau S, Rahalison L, Ralafiarisoa L, et al. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet 2003, 361:211.
57. Fatal human plague- Arizona and Colorado, 1996. MMWR 1997, 46:617. Centers for Disease Control and Prevention.
58. Boulanger L, Ettestad P, Fogarty J, et al. Gentamicin and tetracyclines for the treatment of human plague: Review of 75 cases in New Mexico, 1985-1999. Clin Infect Dis 2004, 38:663.
59. Frean JA, Arntzen L, Capper T, et al. In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus. Antimicrob Agents Chemother 1996, 40:2646.
60. Russell P, Eley SM, Bell DL, et al. Doxycycline or ciprofloxacin prophylaxis and therapy against experimental Yersinia pestis infection in mice. J Antimicrob Chemother 1996, 37:769.
61. Galimand M, Guiyoule A, Gerbaud G, et al. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N Engl J Med 1997, 337:677.
62. Prevention of plague. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1996, 45:1. Centers for Disease Control and Prevention.
63. Technical guide for a system of plague surveillance. Wkly Epidemiol Rec 1973, 14:149. World Health Organization.
64. Fritz CL, Dennis DT, Tipple MA, et al. Surveillance for pneumonic plague in the United States during an international emergency: A model for control of imported emerging diseases. Emerg Infect Dis 1996, 2:30.
65. Titball RW, Williamson ED, Dennis DT Plague. Vaccines 2004, 999. WB Saunders, Philadelphia. 4th ed. S.A. Plotkin, W.A. Orenstein (Eds.).